<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35437355</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1179-142X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>15</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>International medical case reports journal</Title>
          <ISOAbbreviation>Int Med Case Rep J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Oral Albendazole as an Alternative Treatment for Moderate Crusted Scabies Along with 5% Permethrin and 5% Salicylic Acid.</ArticleTitle>
        <Pagination>
          <StartPage>193</StartPage>
          <EndPage>199</EndPage>
          <MedlinePgn>193-199</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2147/IMCRJ.S359928</ELocationID>
        <Abstract>
          <AbstractText>Crusted scabies (CS) is a severe variant of scabies, highly contagious, caused by numerous <i>Sarcoptes scabiei (S. scabiei</i>) infestation. CS is associated with immunosuppressive conditions, like systemic lupus erythematosus (SLE). Various topical and oral scabicidals are used in the treatment of CS, including topical sulfur compounds, benzyl benzoate, crotamiton, lindane, malathion, permethrin, and ivermectin. The treatment of CS does not only need scabicidals, but also keratolytic agents to remove the thick crusts. The severity of CS is classified into three levels and related to the dose of oral ivermectin treatment. When oral ivermectin is not available, oral albendazole can be used as an alternative treatment. A case of CS in a 21-year-old girl with SLE was reported. Physical examination showed multiple lesions in the form erythematous papules, plaques, scales, and hyperkeratotic crusts in almost all parts of the body. The distribution of crusting &gt;30% body surface area, the depth of crusting &gt;10 mm, and there were pyoderma. Sarcoptes scabiei, eggs, and scybala were found on skin scraping. The patient was diagnosed as a moderate CS and treated with occlusive dressings using 5% salicylic acid in vaseline until crusts fell off, 5% permethrin cream three times per week, and 800 mg/day albendazole three consecutive days per week. A clinical and microscopic cure was achieved at day 19 of observation. Albendazole is an antiprotozoal agent with larvicidal effect, therefore it can be used as an alternative treatment of CS when oral ivermectin is unavailable, along with 5% permethrin and 5% salicylic acid.</AbstractText>
          <CopyrightInformation>© 2022 Gunawan et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gunawan</LastName>
            <ForeName>Hendra</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0002-6924-0833</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin Hospital, Bandung, Indonesia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Banjarnahor</LastName>
            <ForeName>Ivan Daniel</ForeName>
            <Initials>ID</Initials>
            <Identifier Source="ORCID">0000-0001-7644-0510</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin Hospital, Bandung, Indonesia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Achdiat</LastName>
            <ForeName>Pati Aji</ForeName>
            <Initials>PA</Initials>
            <Identifier Source="ORCID">0000-0002-3010-5052</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin Hospital, Bandung, Indonesia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int Med Case Rep J</MedlineTA>
        <NlmUniqueID>101566269</NlmUniqueID>
        <ISSNLinking>1179-142X</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">albendazole</Keyword>
        <Keyword MajorTopicYN="N">crusted scabies</Keyword>
        <Keyword MajorTopicYN="N">permethrin</Keyword>
        <Keyword MajorTopicYN="N">salicylic acid</Keyword>
      </KeywordList>
      <CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35437355</ArticleId>
        <ArticleId IdType="pmc">PMC9013267</ArticleId>
        <ArticleId IdType="doi">10.2147/IMCRJ.S359928</ArticleId>
        <ArticleId IdType="pii">359928</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Karthikeyan K. Crusted scabies. Indian J Dermatol Venereol Leprol. 2009;75(4):340. doi:10.4103/0378-6323.53128</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0378-6323.53128</ArticleId>
            <ArticleId IdType="pubmed">19584457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Currier RW, Walton SF, Currie BJ. Scabies in animals and humans: history, evolutionary perspectives, and modern clinical management. Ann N Y Acad Sci. 2011;1230(1):E50–E60. doi:10.1111/j.1749-6632.2011.06364.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1749-6632.2011.06364.x</ArticleId>
            <ArticleId IdType="pubmed">22417107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Welch E, Romani L, Whitfeld MJ. Recent advances in understanding and treating scabies. Fac Rev. 2021;10:10. doi:10.12703/r/10-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12703/r/10-10</ArticleId>
            <ArticleId IdType="pmc">PMC8009191</ArticleId>
            <ArticleId IdType="pubmed">33817697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gutte RM. Bullous scabies in an adult: a case report with review of literature. Indian Dermatol Online J. 2013;4(4):311. doi:10.4103/2229-5178.120654</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/2229-5178.120654</ArticleId>
            <ArticleId IdType="pmc">PMC3853899</ArticleId>
            <ArticleId IdType="pubmed">24350014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panigrahi A, Sil A, Bhanja DB. Pruritic curvilinear track over penis. J Paediatr Child Health. 2020;2020:27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8318537</ArticleId>
            <ArticleId IdType="pubmed">34336052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sil A, Mondal S, Bhanja DB, Datta M, Mukherjee GS, Chakraborty S. Pruritic genital nodules. Pediatr Neonatol. 2020;61(2):243–244. doi:10.1016/j.pedneo.2019.12.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pedneo.2019.12.004</ArticleId>
            <ArticleId IdType="pubmed">31901313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sil A, Punithakumar EJ, Chakraborty S, Bhanja DB, Panigrahi A, Das A. Crusted scabies. Postgrad Med J. 2020;96(1137):444. doi:10.1136/postgradmedj-2020-137661</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/postgradmedj-2020-137661</ArticleId>
            <ArticleId IdType="pubmed">32217744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuura H, Senoo A, Saito M, Fujimoto Y. Norwegian scabies. Cleve Clin J Med. 2019;86(3):163. doi:10.3949/ccjm.86a.18081</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3949/ccjm.86a.18081</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hatter AD, Soler DC, Curtis C, et al. Case report of individual with cutaneous immunodeficiency and novel 1p36 duplication. Clin Genet. 2016;9:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4716770</ArticleId>
            <ArticleId IdType="pubmed">26834495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts LJ, Huffam SE, Walton SF, et al. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect. 2005;50(5):375–381. doi:10.1016/j.jinf.2004.08.033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2004.08.033</ArticleId>
            <ArticleId IdType="pubmed">15907543</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maharani CS, Harnanti DV, Mappamasing H, et al. Crusted scabies in patients with long-term use of oral corticosteroid with different underlying diseases–case series. Dermatol Rep. 2019;11:1.</Citation>
        </Reference>
        <Reference>
          <Citation>Ayoub N, Merhy M, Tomb R. Treatment of scabies with albendazole. Dermatol. 2009;218(2):175. doi:10.1159/000182254</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000182254</ArticleId>
            <ArticleId IdType="pubmed">19060459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Douri T, Shawaf AZ. Treatment of crusted scabies with albendazole: a case report. Dermatol Online J. 2009;15(2):117–126. doi:10.1016/0006-2944(75)90147-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-2944(75)90147-7</ArticleId>
            <ArticleId IdType="pubmed">19951635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Engelman D, Yoshizumi J, Hay RJ, et al. The 2020 international alliance for the control of scabies consensus criteria for the diagnosis of scabies. Br J Dermatol. 2020;183(5):808–820. doi:10.1111/bjd.18943</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjd.18943</ArticleId>
            <ArticleId IdType="pmc">PMC7687112</ArticleId>
            <ArticleId IdType="pubmed">32034956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis JS, McGloughlin S, Tong SY, et al. A novel clinical grading scale to guide the management of crusted scabies. PLoS Negl Trop Dis. 2013;7:e2387. doi:10.1371/journal.pntd.0002387</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0002387</ArticleId>
            <ArticleId IdType="pmc">PMC3772049</ArticleId>
            <ArticleId IdType="pubmed">24069468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mak A, Kow NY. The pathology of T cells in systemic lupus erythematosus. J Immunol Res. 2014;2014:1–8. doi:10.1155/2014/419029</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/419029</ArticleId>
            <ArticleId IdType="pmc">PMC4017881</ArticleId>
            <ArticleId IdType="pubmed">24864268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for disease Control and Prevention Parasites. Scabies, resources for health professionals. Available from: https://www.cdc.gov/parasites/scabies/health_professionals/meds.html. Accessed March
15, 2022.</Citation>
        </Reference>
        <Reference>
          <Citation>Bernigaud C, Fang F, Fischer K, et al. Efficacy and pharmacokinetics evaluation of a single oral dose of afoxolaner against Sarcoptes scabiei in the porcine scabies model for human infestation. Antimicrob Agents Chemother. 2018;62(9):e02334–17. doi:10.1128/AAC.02334-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.02334-17</ArticleId>
            <ArticleId IdType="pmc">PMC6125498</ArticleId>
            <ArticleId IdType="pubmed">29914951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mounsey KE, Bernigaud C, Chosidow O, et al. Prospects for moxidectin as a new oral treatment for human scabies. PLoS Negl Trop Dis. 2016;10(3):e0004389. doi:10.1371/journal.pntd.0004389</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0004389</ArticleId>
            <ArticleId IdType="pmc">PMC4795782</ArticleId>
            <ArticleId IdType="pubmed">26985995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Risadini MW, Mochtar M, Danarti R. Comparison of albendazole tablets with 5% permethrin cream for scabies treatment at AL muayyad Islamic boarding school surakarta [translated title]. Media Dermato Venereologica Indonesiana. 2017;44(3):108–112.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
